Cadila Healthcare informs about press release

29 May 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated May 29, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Fluphenazine Hydrochloride Tablets’. Bring this news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

929.05 6.60 (0.72%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×